Sanctuary Advisors’s Neuronetics STIM Stock Holding History

Sanctuary Advisors’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-88,931	Closed	-$327K	–	2444
2025 Q1	$327K	Buy	+88,931	New	+$325K	﹤0.01%	1739

Other funds holding STIM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

MHP

Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

Sanctuary Advisors's STIM Position: Q2 2025 in Review

Sanctuary Advisors sold out of Neuronetics (STIM) in Q2 2025, closing a stake of 88,931 shares — an estimated $327K sold.

Sanctuary Advisors first reported a position in STIM in Q1 2025 and held it in 1 quarter. The position peaked at $327K in Q1 2025. 90 funds tracked by Wall St. Rank hold STIM as of Q2 2025.

Sanctuary Advisors reported no remaining Neuronetics position as of Q2 2025 after selling out during the quarter.
Sanctuary Advisors sold 88,931 Neuronetics shares in Q2 2025, an estimated $327K.
Sanctuary Advisors first reported a position in Neuronetics in Q1 2025 and held it in 1 quarter.
Sanctuary Advisors's Neuronetics position peaked at $327K in Q1 2025.
90 funds tracked by Wall St. Rank held Neuronetics as of Q2 2025.

Based on Sanctuary Advisors's 13F filing for Q2 2025, filed 6 Jan 2026.